Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the ...
Wearable devices have pulled terms like "REM sleep" from scientific literature to daily discussion points. But what can ...
ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...
The American Heart Association says heart diseases are the leading cause of death in the US. Experts tell Digital Trends that ...
In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...
Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
For a limited time the Apple Watch 10 (GPS/42mm) is on sale for $319 at Amazon. This is $80 off and the lowest price I’ve ...
The RingConn Gen 2 is one of the three recently launched subscription-free smart rings vying for the title of best Oura Ring ...
CR rates new and older models to help you choose the best versionFrom left: Apple Watch Series 10, Ultra 2, and SE.By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback